SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-030359
Filing Date
2019-06-10
Accepted
2019-06-10 09:06:53
Documents
10
Period of Report
2019-06-07
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv523316_8k.htm 8-K 60628
2 EXHIBIT 3.1 tv523316_ex3-1.htm EX-3.1 25390
3 EXHIBIT 10.1 tv523316_ex10-1.htm EX-10.1 29466
4 EXHIBIT 16.1 tv523316_ex16-1.htm EX-16.1 3470
5 EXHIBIT 99.1 tv523316_ex99-1.htm EX-99.1 11845
6 GRAPHIC tv523316_ex99-1img01.jpg GRAPHIC 7086
7 GRAPHIC tv523316_ex3-1img01.jpg GRAPHIC 10003
8 GRAPHIC tv523316_ex3-1img02.jpg GRAPHIC 2845
9 GRAPHIC image_001.jpg GRAPHIC 2669
10 GRAPHIC image_002.jpg GRAPHIC 2255
  Complete submission text file 0001144204-19-030359.txt   167501
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 19887652
SIC: 2834 Pharmaceutical Preparations